Next Article in Journal
Microscopic Polyangiitis Presenting with Splenic Infarction: A Case Report
Previous Article in Journal
Associations between Physical Function, Bone Density, Muscle Mass and Muscle Morphology in Older Men with Sarcopenia: A Pilot Study

Neuropsychiatric Consequences of Lipophilic Beta-Blockers

Department of Medical Specialties (I), Faculty of Medicine, “Grigore T Popa” University of Medicine and Pharmacy, University Street nr 16, 700115 Iasi, Romania
Clinical Rehabilitation Hospital–Cardiovascular Rehabilitation Clinic, Pantelimon Halipa Street nr 14, 700661 Iasi, Romania
Institute of Cardiovascular Disease “Prof. Dr. George. I.M. Georgescu”, Carol I Boulevard nr 50, 700503 Iasi, Romania
Author to whom correspondence should be addressed.
Academic Editor: Mirko Manchia
Medicina 2021, 57(2), 155;
Received: 29 December 2020 / Revised: 4 February 2021 / Accepted: 6 February 2021 / Published: 9 February 2021
Beta-blockers are a class of drugs with important benefits in cardiovascular pathology. In this paper, we aim to highlight their adverse and therapeutic effects in the neuropsychiatric field. With respect to permeability, we would like to mention that most beta-blockers are lipophilic and can cross the blood–brain barrier. Observational studies show the presence of neuropsychiatric side effects when taking beta-blockers, and is the reason for which caution is recommended in their use in patients with depressive syndrome. From a therapeutic point of view, most current evidence is for the use of beta-blockers in migraine attacks, essential tremor, and akathisia. Beta-blockers appear to be effective in the treatment of aggressive behavior, beneficial in the prevention of posttraumatic stress syndrome and may play a role in the adjuvant treatment of obsessive–compulsive disorder, which is refractory to standard therapy. In conclusion, the relationship between beta-blockers and the central nervous system appears as a two-sided coin. Summarizing the neuropsychiatric side effects of beta-blockers, we suggest that clinicians pay special attention to the pharmacological properties of different beta-blockers. View Full-Text
Keywords: beta-blockers; depression; fatigue; propranolol; migraine beta-blockers; depression; fatigue; propranolol; migraine
Show Figures

Figure 1

MDPI and ACS Style

Cojocariu, S.A.; Maștaleru, A.; Sascău, R.A.; Stătescu, C.; Mitu, F.; Leon-Constantin, M.M. Neuropsychiatric Consequences of Lipophilic Beta-Blockers. Medicina 2021, 57, 155.

AMA Style

Cojocariu SA, Maștaleru A, Sascău RA, Stătescu C, Mitu F, Leon-Constantin MM. Neuropsychiatric Consequences of Lipophilic Beta-Blockers. Medicina. 2021; 57(2):155.

Chicago/Turabian Style

Cojocariu, Sabina A., Alexandra Maștaleru, Radu A. Sascău, Cristian Stătescu, Florin Mitu, and Maria M. Leon-Constantin. 2021. "Neuropsychiatric Consequences of Lipophilic Beta-Blockers" Medicina 57, no. 2: 155.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop